Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Gisslinger Heinz and Klade Christoph and Georgiev Pencho and Krochmalczyk Dorota and Gercheva-Kyuchukova Liana and Rossiev Viktor and Dulicek Petr and Illés Árpád and Arpad Pylypenko and Halyna Sivcheva and Lylia Mayer and Egyed Miklós and Borbényi Zita and Masszi Tamás and PROUD-PV Study Group (kollab. közrem.): Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
LANCET HAEMATOLOGY, 7 (3). e196-e208. ISSN 2352-3026 (2020)

[thumbnail of Gisslinger2020.pdf]
Preview
Text
Gisslinger2020.pdf - Published Version

Download (427kB) | Preview
Item Type: Journal Article
Szerzők száma: 43
Journal or Publication Title: LANCET HAEMATOLOGY
Date: 2020
Volume: 7
Number: 3
Page Range: e196-e208
ISSN: 2352-3026
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31303426
DOI azonosító: https://doi.org/10.1016/S2352-3026(19)30236-4
Date Deposited: 2022. Jan. 28. 14:24
Last Modified: 2022. Jan. 28. 14:24
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/23339
Web of Science® Times Cited: 113 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year